Stonehage Fleming Financial Services Holdings Ltd Has $238,000 Stock Position in Zoetis Inc. $ZTS

Stonehage Fleming Financial Services Holdings Ltd reduced its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 99.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,888 shares of the company’s stock after selling 624,554 shares during the quarter. Stonehage Fleming Financial Services Holdings Ltd’s holdings in Zoetis were worth $238,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. SeaCrest Wealth Management LLC lifted its position in Zoetis by 9.7% during the 4th quarter. SeaCrest Wealth Management LLC now owns 2,137 shares of the company’s stock worth $269,000 after buying an additional 189 shares in the last quarter. Czech National Bank boosted its stake in shares of Zoetis by 3.2% during the 4th quarter. Czech National Bank now owns 116,205 shares of the company’s stock worth $14,621,000 after buying an additional 3,645 shares during the last quarter. Salvus Wealth Management LLC grew its holdings in shares of Zoetis by 4.0% in the 4th quarter. Salvus Wealth Management LLC now owns 4,439 shares of the company’s stock valued at $559,000 after acquiring an additional 172 shares in the last quarter. Curated Wealth Partners LLC increased its position in shares of Zoetis by 14.0% in the fourth quarter. Curated Wealth Partners LLC now owns 8,216 shares of the company’s stock valued at $1,034,000 after acquiring an additional 1,012 shares during the last quarter. Finally, Pensionfund Sabic acquired a new stake in shares of Zoetis in the fourth quarter valued at about $1,321,000. Institutional investors own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

ZTS has been the subject of several recent research reports. Piper Sandler reissued a “neutral” rating and set a $135.00 price target (down from $190.00) on shares of Zoetis in a research report on Thursday, January 22nd. Morgan Stanley set a $160.00 price objective on Zoetis in a research note on Thursday, December 18th. Bank of America increased their price objective on Zoetis from $135.00 to $140.00 and gave the company a “neutral” rating in a report on Friday, February 13th. BTIG Research reissued a “buy” rating and issued a $160.00 target price on shares of Zoetis in a research note on Thursday, February 26th. Finally, The Goldman Sachs Group upgraded shares of Zoetis to a “buy” rating in a report on Monday, December 15th. Six investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $152.91.

Zoetis Trading Down 0.1%

Zoetis stock opened at $116.62 on Friday. The stock has a 50-day simple moving average of $123.62 and a 200 day simple moving average of $129.58. The stock has a market capitalization of $49.23 billion, a P/E ratio of 19.37, a PEG ratio of 1.78 and a beta of 0.95. The company has a debt-to-equity ratio of 2.71, a quick ratio of 1.94 and a current ratio of 3.03. Zoetis Inc. has a 52 week low of $113.30 and a 52 week high of $172.23.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, February 12th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.08. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The firm had revenue of $2.39 billion for the quarter, compared to analyst estimates of $2.36 billion. During the same quarter in the prior year, the company earned $1.40 earnings per share. The business’s revenue for the quarter was up 3.0% compared to the same quarter last year. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be paid a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date is Monday, April 20th. Zoetis’s dividend payout ratio is 35.22%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.